JNJ-54861911

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for JNJ-54861911, covering 2014-01-14 to 2025-04-29. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of JNJ-54861911 in Participants With Early Alzheimer's Disease [Phase 2]